Nisa Investment Advisors
TXG icon

Nisa Investment Advisors’s 10x Genomics TXG Stock Holding History

Nisa Investment Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
5,586
+646
+13% +$16.9K ﹤0.01% 1225
2026
Q1 		$105K Buy
4,940
+2,526
+105% +$50.5K ﹤0.01% 1403
2025
Q4 		$39.4K Hold
2,414
– – ﹤0.01% 1698
2025
Q3 		$28.2K Buy
2,414
+568
+31% +$7.41K ﹤0.01% 1836
2025
Q2 		$21.4K Buy
+1,846
New +$16.8K ﹤0.01% 1906
2025
Q1 		– Sell
-16,500
Closed -$237K – 3061
2024
Q4 		$237K Buy
+16,500
New +$260K ﹤0.01% 1246
2024
Q2 		– Sell
-28,200
Closed -$1.06M – 2975
2024
Q1 		$1.06M Hold
28,200
– – 0.01% 867
2023
Q4 		$1.58M Hold
28,200
– – 0.01% 725
2023
Q3 		$1.16M Hold
28,200
– – 0.01% 825
2023
Q2 		$1.57M Hold
28,200
– – 0.01% 739
2023
Q1 		$1.57M Hold
28,200
– – 0.01% 722
2022
Q4 		$1.03M Buy
+28,200
New +$922K 0.01% 905
2022
Q3 		– Sell
-16,600
Closed -$751K – 2638
2022
Q2 		$751K Buy
16,600
+12,800
+337% +$664K 0.01% 917
2022
Q1 		$289K Buy
+3,800
New +$332K ﹤0.01% 1238
2021
Q4 		– Sell
-900
Closed -$131K – 2326
2021
Q3 		$131K Sell
900
-22,338
-96% -$3.84M ﹤0.01% 1583
2021
Q2 		$4.55M Buy
23,238
+18,600
+401% +$3.37M 0.03% 472
2021
Q1 		$839K Hold
4,638
– – 0.01% 1028
2020
Q4 		$657K Buy
4,638
+2,655
+134% +$385K ﹤0.01% 1077
2020
Q3 		$247K Buy
+1,983
New +$208K ﹤0.01% 1255

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nisa Investment Advisors's TXG Position: Q2 2026 in Review

Nisa Investment Advisors increased its 10x Genomics (TXG) stake by 13% in Q2 2026, buying an estimated $16.9K and bringing the position to 5,586 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Nisa Investment Advisors first reported a position in TXG in Q3 2020 and has held it in 19 quarters since. The position peaked at $4.55M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Nisa Investment Advisors held 5,586 shares of 10x Genomics worth $214K as of Q2 2026.
  • Nisa Investment Advisors bought 646 10x Genomics shares in Q2 2026, an estimated $16.9K.
  • 10x Genomics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1225 holding.
  • Nisa Investment Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 19 quarters since.
  • Nisa Investment Advisors's 10x Genomics position peaked at $4.55M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.